- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Acuson exhibits IVUS catheter at AHA show
Acuson of Mountain View, CA, demonstrated a 64-channel intravascular ultrasound catheter as a work-in-progress for cardiac imaging at last month's American Heart Association meeting in Dallas. The company believes that the side-fire catheter should be
Acuson of Mountain View, CA, demonstrated a 64-channel intravascular ultrasound catheter as a work-in-progress for cardiac imaging at last month's American Heart Association meeting in Dallas. The company believes that the side-fire catheter should be more versatile than one-channel IVUS catheters.
The catheter is placed in the right atrium for intracardiac imaging and provides better image quality than a transthoracic or transesophageal probe, according to the company. It supports color Doppler, Doppler Tissue Imaging, spectral imaging, and almost all imaging techniques available on the Aspen or Sequoia scanners.
Acuson has an investigational device exemption for the transducer and is conducting clinical trials for the probe. The company plans to file a 510(k) application next year.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
